Leukemia: Clinical Trials

25 trials for Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 suspended. 25 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 125Suspended 25
Phase 26Suspended 6

Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia
Actinium Ac 225 Lintuzumab, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia
Phase 1SuspendedNational Cancer Institute (NCI)532026-11-182026-08-24
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL
Phase 1 / Phase 2SuspendedSymBio Pharmaceuticals432025-06-092026-02-05
Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration - Myelodysplastic Syndrome/Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Phase 1SuspendedCity of Hope Medical Center202025-04-252026-10-20
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia
CAR-T cells( chimeric antigen receptor T cells) - Relapsed/Refractory Acute Myeloid Leukemia(AML)
Phase 1SuspendedHe Huang242025-01-082025-11-24
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia
Phase 1SuspendedNational Cancer Institute (NCI)452024-12-182026-08-25
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia
Phase 1SuspendedCity of Hope Medical Center242024-11-062026-11-12
DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial
Decoy-resistant interleukin-18, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 1SuspendedFred Hutchinson Cancer Center402024-09-232026-08-10
2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML
CRD3874 - Acute Myeloid Leukemia
Phase 1SuspendedUniversity of Maryland, Baltimore62024-08-262026-03-12
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1SuspendedCity of Hope Medical Center332024-05-242026-10-15
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
CD4CAR - Acute Myeloid Leukemia
Phase 1SuspendedHuda Salman302024-03-192026-09-30
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
CD4CAR - Chronic Myelomonocytic Leukemia
Phase 1SuspendedHuda Salman302024-02-212026-09-24
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
WU-CART-007 - T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia
Phase 1SuspendedWashington University School of Medicine62023-10-102026-07-21
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
8-Chloroadenosine, Venetoclax - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Phase 1SuspendedCity of Hope Medical Center302022-10-312026-10-20
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Vactosertib, Fludarabine Phosphate, Cyclophosphamide - Colorectal Cancer, Hematologic Malignancy
Phase 1SuspendedDavid Wald122022-09-092026-07-14
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
fadraciclib - Leukemia, Myelodysplastic Syndrome(MDS)
Phase 1 / Phase 2SuspendedCyclacel Pharmaceuticals, Inc.2102021-10-222024-02-08
A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia
SY-2101, Arsenic Trioxide - Acute Promyelocytic Leukemia
Phase 1SuspendedSyros Pharmaceuticals162021-09-172024-01-23
Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
anti-TRBC1 CAR-T cell therapy - Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma
Phase 1SuspendedShanghai General Hospital, Shanghai Jiao Tong University School of Medicine92021-03-312023-11-29
Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia
IBI188, Azacitidine, Decitabine - Acute Myeloid Leukemia
Phase 1 / Phase 2SuspendedInnovent Biologics (Suzhou) Co. Ltd.2222020-09-252023-10-23
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2SuspendedCuris, Inc.3662020-07-062026-03-19
Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
Decitabine, Pembrolizumab, Venetoclax - Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 1SuspendedCity of Hope Medical Center542020-05-192026-10-20

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Leukemia, Myeloid, Acute (15)  ·  Myelodysplastic Syndromes (8)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Immunoblastic Lymphadenopathy (3)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Hematologic Neoplasms (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma (2)  ·  Lymphoma, Large-Cell, Anaplastic (2)  ·  Lymphoma, T-Cell (2)  ·  Lymphoma, T-Cell, Peripheral (2)  ·  Recurrence (2)  ·  Burkitt Lymphoma (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Hematologic Diseases (25)  ·  Hemic and Lymphatic Diseases (25)  ·  Neoplasms by Histologic Type (25)  ·  Neoplasms (24)  ·  Leukemia, Myeloid (17)  ·  Bone Marrow Diseases (9)  ·  Immune System Diseases (9)  ·  Immunoproliferative Disorders (9)  ·  Leukemia, Lymphoid (9)  ·  Lymphatic Diseases (9)  ·  Lymphoproliferative Disorders (9)  ·  Disease Attributes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)

Interventions

Specimen Handling (6)  ·  venetoclax (6)  ·  Azacitidine (3)  ·  Biopsy (3)  ·  Cyclophosphamide (2)  ·  Decitabine (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Melphalan (2)  ·  Tacrolimus (2)  ·  fludarabine (2)  ·  fludarabine phosphate (2)  ·  8-chloroadenosine (1)  ·  Actinium (1)  ·  Antibodies, Monoclonal (1)  ·  Arsenic Trioxide (1)

Sponsors

City of Hope Medical Center (5)  ·  Huda Salman (2)  ·  National Cancer Institute (NCI) (2)  ·  Curis, Inc. (1)  ·  Cyclacel Pharmaceuticals, Inc. (1)  ·  David Wald (1)  ·  Fred Hutchinson Cancer Center (1)  ·  He Huang (1)  ·  Humanigen, Inc. (1)  ·  Innovent Biologics (Suzhou) Co. Ltd. (1)  ·  MedImmune LLC (1)  ·  Piramal Enterprises Limited (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  SymBio Pharmaceuticals (1)

Countries

United States (20)  ·  China (5)  ·  Australia (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Alan S. Wayne, MD (1)  ·  Amandeep Salhotra (1)  ·  Annie P Im (1)  ·  Benjamin Tomlinson, MD (1)  ·  Dr Alexey V Danilov, MD, PhD (1)  ·  Dr Jennifer R Brown, MD, PhD (1)  ·  Elizabeth Krakow (1)  ·  Geoffrey Uy, M.D. (1)  ·  Hongtao Liu (1)  ·  Huda Salman, MD, PhD (1)  ·  Ibrahim Aldoss (1)  ·  Jennifer Schwartz, MD (1)  ·  Jiong HU, M.D., (1)  ·  Manu Pandey (1)

Results publications

PMID 27736729, PMID 40020161

NIH funding

P30CA033572 (5), P30CA014599 (1), UM1CA186689 (1), UM1CA186690 (1)